Tectonic Therapeutic (TECX) Interest Coverage Ratio (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Interest Coverage Ratio of 0.95 for Q1 2026, up 99.21% year-over-year from 0.48 in Q1 2025, and up 99.95% quarter-over-quarter from 1793.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Interest Coverage Ratio for 10 consecutive years, with 0.95 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 99.21% year-over-year to 0.95; the TTM figure through Mar 2026 stood at 3.24 (up 99.23% YoY), while the FY2025 annual figure was 0.44, down 30.5% from the prior year.
- Interest Coverage Ratio improved to 0.95 in Q1 2026 per TECX's latest filing, from 1793.0 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.59 in Q3 2024 and bottomed at 1793.0 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 255.74 across 5 years, with a median of 24.99 in 2024.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 112964.97% — and 2026, when it jumped 99.21%.
- Tectonic Therapeutic's Interest Coverage Ratio stood at 31.34 in 2022, then slumped by 779.83% to 275.71 in 2023, then tumbled by 130.66% to 635.95 in 2024, then slumped by 181.94% to 1793.0 in 2025, then jumped by 99.95% to 0.95 in 2026.
- Business Quant data shows TECX's Interest Coverage Ratio at 0.95 in Q1 2026, 1793.0 in Q4 2025, and 4.13 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | -4,036.33 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,036.33 |
| Mar 31, 2026 | -3,412.63 |
| Dec 31, 2025 | -1,793.00 |
| Sep 30, 2025 | -1,563.57 |
| Jun 30, 2025 | -1,313.65 |
| Mar 31, 2025 | -914.90 |
| Dec 31, 2024 | -635.95 |
| Sep 30, 2024 | -785.48 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -418.32 |
| Dec 31, 2023 | -275.71 |
| Sep 30, 2023 | -280.94 |
| Jun 30, 2023 | -265.78 |
| Mar 31, 2022 | -653.73 |
| Jun 30, 2021 | -1,494.05 |
| Mar 31, 2021 | -1,075.36 |
| Dec 31, 2020 | -350.80 |
| Sep 30, 2020 | -496.19 |
| Jun 30, 2020 | -874.45 |
| Mar 31, 2020 | -1,661.81 |